6-(5-Fluoro-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrimidin-4-yl)-2-isopropyl-3,4-dihydroisoquinolin-1(2H)-one

ID: ALA5205035

PubChem CID: 168297332

Max Phase: Preclinical

Molecular Formula: C25H28FN7O

Molecular Weight: 461.55

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)N1CCc2cc(-c3nc(Nc4ccc(N5CCNCC5)cn4)ncc3F)ccc2C1=O

Standard InChI:  InChI=1S/C25H28FN7O/c1-16(2)33-10-7-17-13-18(3-5-20(17)24(33)34)23-21(26)15-29-25(31-23)30-22-6-4-19(14-28-22)32-11-8-27-9-12-32/h3-6,13-16,27H,7-12H2,1-2H3,(H,28,29,30,31)

Standard InChI Key:  UBHPJEJMHASIRC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   -3.5565   -0.0045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5565    0.8204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8448    1.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1358    0.8208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1358   -0.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8430   -0.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4240   -0.4117    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7122   -0.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7122    0.8209    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0021    1.2300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7113    0.8189    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4215    1.2299    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7113    0.0012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0024   -0.4135    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4231   -0.4096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1350    0.0010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8443   -0.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5563    0.0017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2683   -0.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2683   -1.2313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5563   -1.6423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8443   -1.2313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1368   -1.6415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4231   -1.2350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5563   -2.4642    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2683    1.2315    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9800    0.8204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6917    1.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6917    2.0533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9800    2.4642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2683    2.0533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9800   -1.6422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6917   -1.2313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9800   -2.4641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  1  6  2  0
  6  5  1  0
  5  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
 11 10  2  0
 11 12  1  0
 13 11  1  0
  8 14  1  0
 14 13  2  0
 13 15  1  0
 16 15  2  0
 17 16  1  0
 17 18  1  0
 19 18  1  0
 20 19  1  0
 21 20  1  0
 22 17  2  0
 22 21  1  0
 23 22  1  0
 15 24  1  0
 24 23  2  0
 21 25  2  0
  2 26  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 30 29  1  0
 31 30  1  0
 26 31  1  0
 20 32  1  0
 32 33  1  0
 32 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5205035

    ---

Associated Targets(Human)

CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin CDK4/Cyclin D3 (681 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNH Tbio CDK7/Cyclin H/MNAT1 (693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.55Molecular Weight (Monoisotopic): 461.2339AlogP: 3.24#Rotatable Bonds: 5
Polar Surface Area: 86.28Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.81CX Basic pKa: 8.87CX LogP: 3.40CX LogD: 1.93
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.60Np Likeness Score: -1.17

References

1. Chen W, Ji M, Cheng H, Zheng M, Xia F, Min W, Yang H, Wang X, Wang L, Cao L, Yuan K, Yang P..  (2022)  Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer.,  65  (22.0): [PMID:36350721] [10.1021/acs.jmedchem.2c00947]

Source